Showing 4,121 - 4,140 results of 18,261 for search 'significantly ((((((we decrease) OR (a decrease))) OR (larger decrease))) OR (greater decrease))', query time: 0.63s Refine Results
  1. 4121
  2. 4122
  3. 4123

    BT9 reduces DAOY and D425 medulloblastoma cell invasion. by Zahra Motahari (6814013)

    Published 2024
    “…(C) Compared to control, BT9 treatment significantly decreased the number of invading DAOY and D425 cells (****p < 0.0001, BT9 vs vehicle control, n = 6). 4x magnification.…”
  4. 4124
  5. 4125
  6. 4126
  7. 4127
  8. 4128

    Oligonucleotides used in this study. by Aga E. Gelgie (17661720)

    Published 2024
    “…In comparison to the parent strain, the 0690::Tn mutant displayed markedly reduced fitness, as evidenced by a significant decrease or even absence in post-challenge mycoplasma counts in murine and cow mammary tissues, respectively. …”
  9. 4129

    Data supporting the findings of this study. by Aga E. Gelgie (17661720)

    Published 2024
    “…In comparison to the parent strain, the 0690::Tn mutant displayed markedly reduced fitness, as evidenced by a significant decrease or even absence in post-challenge mycoplasma counts in murine and cow mammary tissues, respectively. …”
  10. 4130
  11. 4131
  12. 4132

    Open data. by Larissa Brazolotto Ferreira (17671168)

    Published 2025
    “…</p><p>Results</p><p>There was a significant decrease in BMD in the lumbar spine (1.107 ± 0.109 and 1.075 ± 0.112 g/cm<sup>2</sup>; <i><i>p</i></i> < 0.001), total body (1.135 ± 0.086 and 1.119 ± 0.085 g/cm<sup>2</sup>; <i><i>p</i></i> < 0.001), and total proximal femur over the six months of EBF compared to the values obtained from the same EBF group at 15 days postpartum (mean percentage decreases in BMD of −3.4 ± 3.7% (<i><i>p</i></i> < 0.001) in lumbar spine, −2.5 ± 3.4% (<i><i>p</i></i> < 0.001) in total proximal femur, and −1.7 ± 1.9% (<i><i>p</i></i> = 0.001) in total body). …”
  13. 4133
  14. 4134
  15. 4135
  16. 4136
  17. 4137

    Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

    Published 2024
    “…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”
  18. 4138

    Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

    Published 2024
    “…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”
  19. 4139

    Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

    Published 2024
    “…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”
  20. 4140

    DIP grouping and aggregation system. by Chenxuan Zhu (22622476)

    Published 2025
    “…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β<sub>1</sub> + β<sub>3</sub> = −3.12). …”